(Total Views: 508)
Posted On: 05/02/2019 7:27:11 AM
Post# of 72445
March 31st 2019- This was the day that many claimed would be the last breathe of IPIX.
———————————-
Where is the money to pay salaries, perform business duties, pay rent, etc. etc.?? Extrapolate the percentage sells over the month and clearly it’s not enough to keep everything afloat if the MFO is converting and dumping.
Did anyone know that “non-refundable” milestone payments can be made from a partner to the small biotech company before release of said partnership if an NDA dictates its non disclosure?
It just so happens that Dr. B stated that the receipt of minutes were a significant milestone.
Other relatable milestones-
1. Patent establishments
2. Compound designations
3. IND filing
4. Positioning for major market entries (maybe EU?)
5. Phase 3 trial establishment
Sound familiar???????
http://www.iphandbook.org/handbook/ch12/p08/
For your viewing pleasure...
———————————-
Where is the money to pay salaries, perform business duties, pay rent, etc. etc.?? Extrapolate the percentage sells over the month and clearly it’s not enough to keep everything afloat if the MFO is converting and dumping.
Did anyone know that “non-refundable” milestone payments can be made from a partner to the small biotech company before release of said partnership if an NDA dictates its non disclosure?
It just so happens that Dr. B stated that the receipt of minutes were a significant milestone.
Other relatable milestones-
1. Patent establishments
2. Compound designations
3. IND filing
4. Positioning for major market entries (maybe EU?)
5. Phase 3 trial establishment
Sound familiar???????
http://www.iphandbook.org/handbook/ch12/p08/
For your viewing pleasure...
(3)
(0)
